A 10-Year Risk Assessment and Primary Prevention Study of Atherosclerotic Cardiovascular Disease Among Adult Patients in Saudi Arabia: A Cross-Sectional Study

<i>Background and Objectives</i>: Cardiovascular diseases (CVDs), primarily driven by atherosclerosis, are the leading cause of mortality worldwide. In Saudi Arabia, the prevalence of atherosclerotic cardiovascular disease (ASCVD) poses a significant public health challenge. To estimate...

Full description

Bibliographic Details
Published in:	Medicina
Main Authors:	Abdulhameed Alkhalaf, Qasem Aljabr, Khalid Al Mulla, Duaa Almubarak, Abdul Sattar Khan, Zainab Y. Al Jaziri, Ibrahim Albahrani
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Subjects:	atherosclerotic cardiovascular disease (ASCVD) 10-year ASCVD risk primary prevention risk factors statin therapy aspirin use
Online Access:	https://www.mdpi.com/1648-9144/61/1/132

Similar Items

Aspirin for Prevention of Atherosclerotic Cardiovascular Disease
by: Soneil Guptha, Eteri Tsetskhladze, Leena S Guptha, Rajeev Gupta
Published: (2025-03-01)

Atherosclerotic cardiovascular disease risk among Ghanaians: A comparison of the risk assessment tools.
by: Francis Agyekum, et al.
Published: (2024-06-01)

Patterns and gaps in guideline-directed statin use for atherosclerotic cardiovascular disease by race and ethnicity
by: Ashish Sarraju, et al.
Published: (2024-03-01)

Performance of the pooled cohort equation in South Asians: insights from a large integrated healthcare delivery system
by: Neha M. Mantri, et al.
Published: (2022-12-01)

Gender disparities in utilization of statins for low density lipoprotein management across the spectrum of atherosclerotic cardiovascular disease: Insights from the houston methodist cardiovascular disease learning health system registry
by: Izza Shahid, et al.
Published: (2024-09-01)

Audit on lipid screening, management and target achievement in prevention of cardiovascular disease in patients attending a medical clinic in National Hospital Kandy: Are we on par with the guidelines?
by: F. N. Nasim, et al.
Published: (2023-02-01)

Obesity and Atherosclerotic Cardiovascular Disease: A Review of Social and Biobehavioral Pathways
by: Izza Shahid, et al.
Published: (2025-02-01)

Impact of the COVID-19 pandemic on the management of risk factors in patients with stable atherosclerotic vascular disease
by: Dean G. Karalis, et al.
Published: (2023-06-01)

Same evidence, varying viewpoints: Three questions illustrating important differences between United States and European cholesterol guideline recommendations
by: David I. Feldman, et al.
Published: (2020-12-01)

Incidence and risk factors regarding atherosclerotic cardiovascular disease in middle-aged and elderly people with HIV treated in Chongqing, China
by: Min Liu, et al.
Published: (2024-12-01)

Prevalence of Tendon Rupture and Tendinopathies Among Patients with Atherosclerotic Cardiovascular Disease Derived From United States Administrative Claims Data
by: Kristin K. Gillard, et al.
Published: (2024-07-01)

Preventive cardiology as a dedicated clinical service: The past, the present, and the (Magnificent) future
by: Michael D. Shapiro, et al.
Published: (2020-03-01)

Cardio-ankle vascular index represents the best surrogate for 10-year ASCVD risk estimation in patients with primary hypertension
by: Mustafa Tarik Agac, et al.
Published: (2021-05-01)

Atherosclerotic cardiovascular disease events among adults with high predicted risk without established risk factors
by: Nathan Kong, et al.
Published: (2024-03-01)

Association between oxidative balance score and 10-year atherosclerotic cardiovascular disease risk: results from the NHANES database
by: Dekui Jin, et al.
Published: (2024-07-01)

Comparative 10-year atherosclerotic cardiovascular disease risk in Ethiopian HIV patients on first-line versus second-line combined antiretroviral therapy
by: Balew Arega, et al.
Published: (2025-09-01)

Adherence to the 2018 AHA cholesterol management guideline in hyperlipidemia treatment among adults in an outpatient setting
by: Bahere Behdani, et al.
Published: (2024-07-01)

Statin utilization and cardiovascular outcomes in a real-world primary prevention cohort of older adults
by: Aaron J. Walker, et al.
Published: (2024-06-01)

Self- vs provider-referral differences for coronary artery calcium testing
by: Rebekah Lantz, et al.
Published: (2022-01-01)

LDL Cholesterol, Statins And PCSK 9 Inhibitors
by: Sanjiv Gupta
Published: (2015-09-01)

Prevalence and Risk Factors for Atherosclerotic Cardiovascular Disease in 7704 Individuals: An Analysis from the Greek Registry for the Prevalence of Familial Hypercholesterolemia (GRegistry-FH)
by: Genovefa Kolovou, et al.
Published: (2024-12-01)

Current Guideline Risk Stratification and Cardiovascular Outcomes in Chinese Patients Suffered From Atherosclerotic Cardiovascular Disease
by: Sha Li, et al.
Published: (2022-04-01)

Prevalence and associated factors of uncontrolled hyperlipidemia among Thai patients with diabetes and clinical atherosclerotic cardiovascular diseases: a cross-sectional study
by: Teeraboon Lertwanichwattana, et al.
Published: (2021-03-01)

Hispanic/Latino ethnic background and genetic ancestry in relation to atherosclerotic cardiovascular disease risk estimation: Findings from the Multi-Ethnic Study of Atherosclerosis (MESA)
by: Bede N. Nriagu, et al.
Published: (2025-09-01)

A risk stratification model modified from the U.S. guideline could be applied in an Asian population with or without ASCVD: Validation study
by: Yu-Chung Hsiao, et al.
Published: (2024-06-01)

Lipoprotein (a) Testing in Patients With Atherosclerotic Cardiovascular Disease in 5 Large US Health Systems
by: Nishant P. Shah, et al.
Published: (2024-11-01)

Future atherosclerotic cardiovascular disease in systemic lupus erythematosus based on CSTAR (XXVIII): the effect of different antiphospholipid antibodies isotypes
by: Can Huang, et al.
Published: (2025-01-01)

Mediation effect of platelet indices on the association of daytime nap duration with 10-year ASCVD risk
by: Erwei Gao, et al.
Published: (2021-01-01)

Demystifying the nuances of the lipid patient: a guide for primary care providers
by: Merle Myerson, et al.
Published: (2025-09-01)

Comparative Analysis of Three Atherosclerotic Cardiovascular Disease Risk Prediction Models in Individuals Aged 75 and Older
by: Wang Z, et al.
Published: (2024-03-01)

2023 UPDATE: Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes
by: Marcello Casaccia Bertoluci, et al.
Published: (2023-07-01)

Comparing the performance of machine learning and conventional models for predicting atherosclerotic cardiovascular disease in a general Chinese population
by: Zihao Fan, et al.
Published: (2023-07-01)

Genetic Predisposition of Atherosclerotic Cardiovascular Disease in Ancient Human Remains
by: Christina Wurst, et al.
Published: (2024-01-01)

Coronary artery calcium and atherosclerotic cardiovascular disease risk in women with early menopause: The Multi-Ethnic Study of Atherosclerosis (MESA)
by: Jian H. Chu, et al.
Published: (2022-09-01)

Elevated Fasting C-Peptide Levels Correlate with Increased 10-Year Risk of Atherosclerotic Cardiovascular Disease in Newly Diagnosed Type 2 Diabetes Patients
by: Zha XY, et al.
Published: (2025-01-01)

The Impact of an Educational Intervention on Enhancing Clinical Knowledge of Physicians and Pharmacists Regarding Statins and Monitoring Parameters: The Experience of a Tertiary Teaching Hospital
by: Al-Ashwal FY, et al.
Published: (2024-04-01)

Retinal vascular alterations as assessment indicators of atherosclerotic cardiovascular disease risk in dyslipidemia patients
by: Yu He, et al.
Published: (2025-09-01)

Impact of remnant cholesterol to high-density lipoprotein cholesterol ratio on risk of incident ASCVD: the Kailuan prospective cohort study
by: Yizhen Tan, et al.
Published: (2025-05-01)

The effect of telemedicine on secondary prevention of atherosclerotic cardiovascular disease: A systematic review and meta-analysis
by: Liangying Deng, et al.
Published: (2022-11-01)

PREVENT Risk Score vs the Pooled Cohort Equations in MESA
by: Brittany Saldivar Murphy, MD, et al.
Published: (2025-06-01)